Snehal Jamalpure

Snehal Jamalpure

B Sc. Biotechnology, M Sc. Microbial Gene Technology

Snehal Jamalpure is a postgraduate student in Microbial gene technology. Following completion of an M.Sc, she worked as a project fellow at the Council of Scientific and Industrial Research-Centre for Cellular and Molecular Biology in Hyderabad, India. Snehal has hands-on experience in protein-related and DNA-related experiments, cell culture, and handling of pathogenic strains (Leishmania donovani) in Biosafety level 3 facilities. Snehal is currently pursuing a Ph.D. in the subject of nanobioscience and is working at the interface of nanotechnology and biology. Snehal has studied nanoparticle synthesis and characterization, standardization and optimization of paper-based diagnostics, and sensor development. Scientific communication and its numerous branches pique her curiosity. To pursue her interests, she has worked on several projects involving scientific content writing, editing, and scientific evaluation of medical literature. Snehal has extensive experience editing and journal formatting scientific manuscripts for international peer-reviewed publications, as well as creating style guides. Snehal is also proficient in data analysis and interpretation using bioinformatics applications such as Autodock, Discovery Studio 7.0, Schrodinger, and GraphPad Prism.  Currently, Snehal is also the team lead for the student science magazine and recently won the National Bio Entrepreneurship Competition which required substantial business proposal writing and presentation skills.

Articles from Snehal

Should SARS-CoV-2 Omicron be considered a serotype?

Should SARS-CoV-2 Omicron be considered a serotype?

Pre-existing B-cell immunity against SARS-CoV-2 not detected in pre-pandemic samples

Pre-existing B-cell immunity against SARS-CoV-2 not detected in pre-pandemic samples

Study reports potently neutralizing mucosal IgA in saliva of BNT162b2 vaccine recipients

Study reports potently neutralizing mucosal IgA in saliva of BNT162b2 vaccine recipients

Study reports a highly attenuated SARS-CoV-2 that could serve as a live-attenuated vaccine platform

Study reports a highly attenuated SARS-CoV-2 that could serve as a live-attenuated vaccine platform

Study looks at COVID-19 vaccine hesitancy in France and Italy

Study looks at COVID-19 vaccine hesitancy in France and Italy

Omicron breakthrough boosts neutralization titers a little more than a 3rd COVID vaccine dose

Omicron breakthrough boosts neutralization titers a little more than a 3rd COVID vaccine dose

Study provides evidence for spike protein-independent attenuation of SARS-CoV-2 Omicron variant

Study provides evidence for spike protein-independent attenuation of SARS-CoV-2 Omicron variant